Viveka Roychowdhury – Page 16 – Express Pharma

Will regulators catch up in 2020?

Rationalising pharma trade margins seems next on the list

Sustainable manufacturing practices to combat growing AMR

Lupin sells stakes in Kyowa but its not a Sayonara

Sustainable manufacturing practices to combat growing AMR

After sartans and ranitidine, where will NDMA show up next?

Slaying GMP non-compliance woes

Heeding the clarion call for sustainability

Price caps are a band aid hiding larger issues

India’s AMR Policy – Get Updated!